Katrin Biesner, Marija Djukić, Utz Reichard, Roland Nau, Jana Seele
OBJECTIVE: Antibiotic resistance in Gram-negative bacteria has become an increasing problem in the treatment of critically ill patients, particularly in central nervous system infections. In clinical practice, MICs and minimal bactericidal concentrations are usually determined in standard test media and not in the respective body fluids. METHODS: . RESULTS: Cefotaxime, ceftazidime, and ciprofloxacin inhibited the growth of Pseudomonas aeruginosa, cefotaxime, ceftazidime and amikacin inhibited the growth of Morganella morganii, and amikacin inhibited the growth of Acinetobacter baumannii in the nutrient-deficient CSF medium at lower concentrations than the MICs determined in MHB. The differences in MIC between MHB and artificial cerebrospinal fluid were less pronounced than between MHB and human CSF. CONCLUSIONS: In central nervous system infections, when antimicrobial susceptibility testing in standard media does not result in adequate therapeutic options, we suggest testing the antimicrobial susceptibility of the causative bacterium in human CSF.